Daslemia 50mg Tablet is a prescription anti-cancer medicine that contains Dasatinib 50mg as its active ingredient. It belongs to a class of medicines known as Tyrosine Kinase Inhibitors (TKIs). This medicine is primarily prescribed for the treatment of Philadelphia chromosome-positive (Ph+) Chronic Myeloid Leukemia (CML) and certain cases of Philadelphia chromosome-positive Acute Lymphoblastic Leukemia (Ph+ ALL). It works by targeting specific proteins responsible for the uncontrolled growth of leukemia cells, helping to slow or stop the progression of the disease.
Daslemia 50mg Tablet is commonly recommended when patients require targeted therapy for blood cancer. Regular use under the supervision of an oncologist helps reduce the number of abnormal white blood cells, supports healthy blood cell production, and improves long-term disease control. Regular blood tests and medical monitoring are necessary during treatment to ensure safety and effectiveness.
For the best results, Daslemia 50mg Tablet should be taken exactly as prescribed by your doctor. Do not stop taking the medicine without medical advice, even if you feel well, as discontinuing treatment may affect disease control.
Composition of Daslemia 50mg Tablet
| Active Ingredient | Strength | Role |
|---|---|---|
| Dasatinib | 50mg | Tyrosine kinase inhibitor that blocks abnormal proteins responsible for the growth and multiplication of leukemia cells. |
Uses of Daslemia 50mg Tablet
- Chronic Myeloid Leukemia (Ph+ CML): Used for the treatment of newly diagnosed or previously treated Philadelphia chromosome-positive chronic myeloid leukemia in adults and eligible patients.
- Acute Lymphoblastic Leukemia (Ph+ ALL): Used in selected patients with Philadelphia chromosome-positive acute lymphoblastic leukemia under specialist supervision.
- Patients Resistant to Previous Therapy: May be prescribed for patients who have developed resistance or intolerance to certain other tyrosine kinase inhibitor treatments.
- Long-Term Cancer Management: Helps control disease progression and maintain remission when taken regularly as directed by an oncologist.
Benefits of Daslemia 50mg Tablet
- Helps slow the growth and spread of leukemia cells.
- Targets cancer cells with a targeted therapy approach.
- Supports long-term management of Philadelphia chromosome-positive leukemia.
- May improve blood cell counts and reduce disease-related symptoms.
- Helps delay disease progression when taken consistently.
- Provides an effective oral treatment option for eligible patients.
- Supports improved treatment outcomes under specialist medical supervision.
-
Side Effects of Daslemia 50mg Tablet
Daslemia 50mg Tablet is generally well tolerated when used under the supervision of an oncologist. However, like all anti-cancer medicines, it may cause side effects. Most side effects are manageable with proper medical care, but some may require immediate attention. Contact your doctor if any side effect becomes severe or persistent.
- Low Blood Cell Counts: Daslemia 50mg Tablet may reduce red blood cells, white blood cells, and platelets, increasing the risk of anemia, infections, and bleeding.
- Fatigue: Feeling tired or weak is one of the most commonly reported side effects during treatment.
- Nausea and Vomiting: Some patients may experience nausea or vomiting, especially during the initial phase of treatment.
- Diarrhea: Loose stools or diarrhea may occur. Drink plenty of fluids and inform your doctor if symptoms persist.
- Headache: Mild to moderate headaches may occur in some patients.
- Muscle and Joint Pain: Pain or discomfort in muscles and joints has been reported during treatment.
- Skin Rash: Some patients may develop mild skin rash, itching, or redness.
- Fluid Retention: Swelling of the hands, feet, ankles, or around the eyes may occur. Severe swelling should be reported immediately.
- Shortness of Breath: Seek immediate medical attention if you develop breathing difficulty or chest discomfort.
- Serious Bleeding: Unusual bruising, bleeding gums, blood in urine, or black stools require urgent medical evaluation.
Precautions and Warnings
- Use Daslemia 50mg Tablet only under the supervision of a qualified oncologist.
- Inform your doctor if you have liver disease, heart disease, bleeding disorders, or lung problems before starting treatment.
- Regular blood tests are necessary to monitor blood cell counts and liver function.
- Avoid pregnancy during treatment. Effective contraception is recommended for both men and women if advised by the treating physician.
- Do not breastfeed while taking Daslemia 50mg Tablet unless your doctor advises otherwise.
- Avoid grapefruit and grapefruit juice as they may increase Dasatinib levels in the body.
- Do not receive live vaccines without consulting your oncologist.
Drug Interactions
Daslemia 50mg Tablet may interact with several medicines. Always inform your healthcare provider about all prescription medicines, over-the-counter drugs, vitamins, and herbal supplements you are taking.
- Antacids containing magnesium or aluminum.
- Proton pump inhibitors (PPIs) and H2 blockers used for acidity.
- Strong CYP3A4 inhibitors (such as ketoconazole and clarithromycin).
- Strong CYP3A4 inducers (such as rifampicin and phenytoin).
- Blood-thinning medicines including warfarin.
- Other anti-cancer medicines and chemotherapy drugs.
Storage Instructions
- Store below 30°C in a cool and dry place.
- Keep the tablets in their original container.
- Protect from moisture and direct sunlight.
- Keep out of reach of children and pets.
- Do not use after the expiry date mentioned on the pack.
Missed Dose
If you miss a dose of Daslemia 50mg Tablet, take the next scheduled dose at the usual time. Do not take two doses together to make up for the missed dose. If you are unsure what to do, consult your oncologist.
Overdose
An overdose of Daslemia 50mg Tablet may increase the risk of serious side effects, including severe bone marrow suppression and bleeding. Seek immediate medical attention or visit the nearest emergency department if an overdose is suspected.
Who Should Avoid Daslemia 50mg Tablet?
- Patients allergic to Dasatinib or any ingredient in the tablet.
- Patients with severe uncontrolled liver disease unless specifically advised by an oncologist.
- Pregnant women unless the potential benefit outweighs the risk.
- Breastfeeding mothers unless advised by their healthcare provider.
- Patients with serious uncontrolled infections should consult their doctor before starting treatment.
Safety Advice
Condition Advice Alcohol Limit or avoid alcohol during treatment. Consult your doctor for individual advice. Pregnancy Not recommended during pregnancy unless clearly prescribed by a specialist. Breastfeeding Breastfeeding is generally not recommended during treatment. Driving Avoid driving if you experience dizziness, fatigue, or blurred vision. Liver Disease Use with caution under close medical supervision. Kidney Disease Use only as advised by your healthcare provider. Habit Forming No, Daslemia 50mg Tablet is not habit-forming. Important Patient Advice
Take Daslemia 50mg Tablet exactly as prescribed and do not stop treatment without consulting your oncologist. Attend all scheduled blood tests and follow-up visits to monitor your response to therapy. Report any signs of fever, infection, unusual bleeding, severe fatigue, chest pain, or difficulty breathing immediately. Maintaining a healthy diet, adequate hydration, and following your doctor’s recommendations can help support your treatment journey.
-
Frequently Asked Questions (FAQs)
1. What is Daslemia 50mg Tablet used for?
Daslemia 50mg Tablet is prescribed to treat Philadelphia chromosome-positive Chronic Myeloid Leukemia (Ph+ CML) and certain cases of Philadelphia chromosome-positive Acute Lymphoblastic Leukemia (Ph+ ALL).
2. What is the active ingredient in Daslemia 50mg Tablet?
The active ingredient is Dasatinib 50mg, a tyrosine kinase inhibitor (TKI).
3. How does Daslemia 50mg Tablet work?
It blocks the abnormal BCR-ABL protein that promotes the growth of leukemia cells, helping slow or stop the progression of the disease.
4. Can Daslemia 50mg Tablet cure leukemia?
Daslemia 50mg Tablet helps control leukemia and slow disease progression. Your oncologist will determine the most appropriate treatment plan based on your condition.
5. How should I take Daslemia 50mg Tablet?
Take the tablet exactly as prescribed by your doctor. Swallow it whole with water, with or without food, at the same time every day.
6. Can I stop taking Daslemia 50mg Tablet if I feel better?
No. Do not stop treatment without consulting your oncologist, as this may affect disease control.
7. What are the common side effects of Daslemia 50mg Tablet?
Common side effects include fatigue, nausea, diarrhea, headache, low blood cell counts, skin rash, swelling, and muscle pain.
8. Is Daslemia 50mg Tablet safe during pregnancy?
No. It should generally be avoided during pregnancy unless your doctor determines the benefits outweigh the risks.
9. Can I breastfeed while taking Daslemia 50mg Tablet?
Breastfeeding is generally not recommended during treatment. Follow your healthcare provider’s advice.
10. Can I drink alcohol while taking Daslemia 50mg Tablet?
Alcohol may increase certain side effects. Consult your doctor before consuming alcoholic beverages during treatment.
11. What should I do if I miss a dose?
Skip the missed dose and take your next dose at the scheduled time. Do not take a double dose.
12. How should I store Daslemia 50mg Tablet?
Store below 30°C in a cool, dry place away from heat, moisture, and direct sunlight.
13. Does Daslemia 50mg Tablet interact with other medicines?
Yes. It may interact with antacids, acid-reducing medicines, blood thinners, antifungal medicines, antibiotics, and several other prescription drugs. Always inform your doctor about all medicines you use.
14. Is Daslemia 50mg Tablet habit-forming?
No. Daslemia 50mg Tablet is not habit-forming.
15. Where can I buy Daslemia 50mg Tablet online?
You can purchase Daslemia 50mg Tablet from licensed online pharmacies with a valid prescription issued by a qualified healthcare professional.
Conclusion
Daslemia 50mg Tablet is a prescription targeted anti-cancer medicine containing Dasatinib 50mg. It is used in the treatment of Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) and certain cases of Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL). When taken exactly as prescribed and combined with regular medical monitoring, it helps control the growth of leukemia cells and supports long-term disease management. Always follow your oncologist’s instructions and attend all scheduled follow-up appointments.
Internal Links
Outbound Links
